Health+Benefits

Next Generation Medicine: Specialty Drug Costs, Data & Supply Chain

The latest specialty drug cost management levers that employers and plan sponsors are considering to deliver meaningful cost savings and improved patient outcomes.
By Katie Oberkircher Posted on September 15, 2021

Specialty drugs accounted for an estimated 40%-50% of drug spend in 2020. An influx of new gene therapies has an expected sales forecast of $16 billion in 2024. 

At the same time, clinical advancements have allowed for the creation of cures and treatments for a number of chronic illnesses and previously untreatable diseases.

Watch the panel discussion from The Council’s Employee Benefits Leadership Forum, which examines contracting strategies, plan design and personalized medicine.

Featuring:

Chris Crawford, Chief Growth Officer, Vivio Health

Joshua Fredell, PharmD, Vice President, Product Development, CVS Health

Laura Jester, Senior Director, Specialty/Pharmacy Solutions, Navitus Health Solutions

Scott Musial, Chief Pharmacy Officer, Rightway Healthcare

Moderated by: Ryan Rice, Principal & Practice Leader, Prism Health Strategists

Katie Oberkircher Director, Health Policy & Strategy Read More
See More: Employer Sponsored Insurance Healthcare Costs Prescription Drug Pricing

More in Health+Benefits

Mental Health and DE&I: The Challenges Employers Aren't Talking About But Should
Health+Benefits Mental Health and DE&I: The Challenges Employers Aren't Talking About But Should
With employers increasingly involving themselves at the point of care, what is t...
Health+Benefits Employers Rethink Healthcare Delivery
Benefits renewal season is here, but the focus is not on rates (yet).
Who Loves Ya, Baby?
Health+Benefits Who Loves Ya, Baby?
Employers now have solid options to support employees who are also caregivers, a...
Going Direct: Primary Care, Subscription Style
Health+Benefits Going Direct: Primary Care, Subscription Style
Q&A with Brian Forrest, M.D., Founder and CEO of Access Healthcare Direct
Broker-Focused Policy
EBLF Broker-Focused Policy
One conversation brokers are not having right now but should...
Stress Testing Future Pandemics: Are We Prepared for What’s Next?
EBLF Stress Testing Future Pandemics: Are We Prepared for What’s Next?
A preview of a new health coverage study.
For many employers that self-fund health insurance benefits for their employees, the COVID-19 pandemic exposed the imprudence of basing a medical stop loss insurance purchasing decision primarily on rates over coverage terms.
EBLF Employer-Funded Health Insurance is More Than a Competitive Rate